13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neuroendocrinologists
Neuroendocrinologists focus on the intricate relationship between the nervous system and the endocrine system, examining how hormones influence brain function and behavior. Their research explores the regulation of metabolism, stress response, and reproductive health through neuroendocrine pathways. They investigate disorders like Cushing's disease, hypothyroidism, and adrenal insufficiency, which affect both the nervous and endocrine systems. By studying the hypothalamic-pituitary-adrenal (HPA) axis, neuroendocrinologists offer insights into conditions involving hormonal imbalances and their neurological consequences. Their work also delves into how stress hormones impact brain development, memory, and mood disorders. Through advanced diagnostic techniques, neuroendocrinologists identify biomarkers and hormonal irregularities linked to neurological disorders. Collaborating with neurology, endocrinology, and psychiatry specialists, they aim to develop treatments that target both systems simultaneously, improving outcomes for patients with dual diagnoses. Their research continues to inform personalized therapies based on individual hormonal profiles. Additionally, neuroendocrinologists are at the forefront of investigating neuroendocrine tumors, providing crucial insights into how these tumors impact brain and hormonal function. Their findings contribute to the development of novel treatment approaches, particularly for complex, multifactorial disorders.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States